FEB 15 2005 K O5021e .
A WaveLight
510(k) Summary of Safety and Effectiveness
This 510(k) Summary of Safety and Effectiveness is being submitted in accordance
with the requirements of the SMDA 1990 and 21 CFR 807.92.
1. General information
Submitter: WaveLight Laser Technologie, AG
Am Wolfsmantel 5
91058 Erlangen
Germany
Contact Person: Alexander Popp
Am Wolfsmantel 5
91058 Erlangen
Germany
Telephone: +49 (0)9131-6186-121
Fax: +49 (0)9131-6186-202
Summary Preparation Date: December 16, 2004
2. Names
Device Name: SINON
Classification Name: Laser Instrument, Surgical Powered
Product Code: GEX
Panel: Dermatology and Plastic Surgery
3. Predicate Devices
This submission refers to the SINON device registered under 510(k) number
K040433. Therefore the SINON described here is substantially equivalent to
the SINON registered under 510(k) number K040433.
The SINON laser system is furthermore substantially equivalent to the
Aesculap-Meditec RubyStar Laser System with Normal and Q-Switch Mode
(K991285), the Spectrum Medical Technologies RD-1200 (K910422), the
MLT Laser Technologies Inc. MLT R694 (K9909002), the Mehl/Biophile Inc.
Chromos 694 (K971814) and WaveLights SINON device (K040384).
0021

—~ | &
ZA WaveLight
510(k) Summary of Safety and Effectiveness
4. Device Description
The SINON is a 694 nm Ruby laser system which can be operated in two
different modes. The quality-switch or Q-switch or QS Operating Mode is
characterized by extremely short pulse widths (ns = 10°s) and high peak
power (MW = 10° W). The QS Operating Mode in the SINON is used for the
removal of tattoos and treatment of pigmented lesions. The second mode is
the Free-Running Operating Mode which is used for the removal of hair.
5. Indications for Use
The SINON is indicated:
1. In the Q-Switch Mode, for the cutting, vaporization, or ablation of soft tissue.
This includes the removal of tattoos and treatment of benign pigmented
lesions.
2. In the Free-Running Mode, for the removal of unwanted hair in patients with
Fitzpatrick skin types of | and Il.
6. Performance Data
None presented.
0022

prey
i & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
. C
Food and Drug Administration
9200 Corporate Boulevard
FEB 15 2005 Rockville MD 20850
Wavelight Laser Technologie AG
; c/o Mr. Morten S. Christensen
Underwriters Laboratories, Inc.
1655 Scott Boulevard
Santa Clara, California 95050
Re: K050218
Trade/Device Name: SINON
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: January 25, 2005
Received: January 31, 2005
Dear Mr. Christensen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Morten S. Christensen
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
, (301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
) Ad 7 ail.
W* Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

em : ®
A WaveLight
510 (k) Indication for Use
a
Indications for Use
510(k) Number (if known): 37 KO50a) &
Device Name: SINON
indications for Use:
4. In the Q-Switch Mode, for the cutting, vaporization, or ablation of soft tissue.
This includes the removal of tattoos and treatment of benign pigmented lesions.
2. In the Free-Running Mode, for the removal of unwanted hair in patients with
. Fitzpatrick skin types of | and Il.
Prescription Use x AND/OR Over-The-Counter Use rue
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF
‘EDED)
/] Ahad Cc e of Device Evaluation (ODE)
™ (Division Sign-Off)
Division of General, Restorative, Page _1_of 1.
and Neurological Devi ces (indication for use only)
KOS ONY
510(k) Number______—— 0020

